Insulin lispro

Details

Generic Name:

Insulin lispro

Project Status:

Cancelled

Manufacturer:

sanofi-aventis Canada Inc.

Call for patient/clinician input open:

September 27, 2017

Brand Name:

Admelog

Project Line:

Reimbursement Review

Project Number:

SE0543-000

Call for patient/clinician input closed:

November 16, 2017

Biosimilar:

Yes

Submission Type:

New

Fee Schedule:

Pending

Indications:

Diabetes mellitus, Type 1 & 2

Last Updated : September 27, 2017